Parkinsonism as a Potential Neurologic Immune-Mediated Adverse Event of Immune Checkpoint Inhibitors.
- DOI
- 10.1212/nxi.0000000000200644
- Published
- 2026 Sep
- Container
- Neurology(R) neuroimmunology & neuroinflammation
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1212/nxi.0000000000200644,
title = {Parkinsonism as a Potential Neurologic Immune-Mediated Adverse Event of Immune Checkpoint Inhibitors.},
author = {Birzu C and Bihan K and Wehrung M and Kas A and Valette F and Pouclet-Courtemanche H and Diop Jaffrelot L and Leclercq D and Palassin P and Gaboriau L and Raimbourg J and Autier L and Farina A and Joubert B and Honnorat J},
year = {2026},
journal = {Neurology(R) neuroimmunology \& neuroinflammation},
doi = {10.1212/nxi.0000000000200644},
url = {https://doi.org/10.1212/nxi.0000000000200644}
}RIS
TY - JOUR TI - Parkinsonism as a Potential Neurologic Immune-Mediated Adverse Event of Immune Checkpoint Inhibitors. AU - Birzu C AU - Bihan K AU - Wehrung M AU - Kas A AU - Valette F AU - Pouclet-Courtemanche H AU - Diop Jaffrelot L AU - Leclercq D AU - Palassin P AU - Gaboriau L AU - Raimbourg J AU - Autier L AU - Farina A AU - Joubert B AU - Honnorat J PY - 2026 JO - Neurology(R) neuroimmunology & neuroinflammation DO - 10.1212/nxi.0000000000200644 UR - https://doi.org/10.1212/nxi.0000000000200644 ER -
APA
C, B., K, B., M, W., A, K., F, V., H, P., L, D. J., D, L., P, P., L, G., J, R., L, A., A, F., B, J., & J, H. (2026). Parkinsonism as a Potential Neurologic Immune-Mediated Adverse Event of Immune Checkpoint Inhibitors.. Neurology(R) neuroimmunology & neuroinflammation. https://doi.org/10.1212/nxi.0000000000200644
Source records
- pubmed · retrieved 2026-09-27T07:37:47.530Z
- europe-pmc · retrieved 2026-09-27T07:37:47.543Z